Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that the Committee ...

The bears will point out that Novo Nordisk is losing ground in the GLP-1 market to its most important competitor, Eli Lilly.

Jaipur: A study by doctors at the govt-run JK Lon Hospital has found that nearly 43% of children with thalassemia who undergo ...

The Human Genome Project, launched in 1990 and completed in 2003, also moved the needle. Scientists had successfully ...

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...

Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year -- Second pivotal development ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...

The social media creator, who had hundreds of thousands of followers across Instagram and TikTok, first went viral during an appearance on the reality show ‘Divorce Court’ Rolling Ray/Instagram A ...

New details about Rolling Ray’s death have emerged. One month after the social media star—who amassed an internet following after appearances on Catfish: Trolls and Divorce Court—died at age 28, his ...

Lyndsey Collins-Praino receives funding from the National Health and Medical Council, the Medical Research Future Fund, the Australian Research Council and various philanthropic organisations. In ...